Page last updated: 2024-10-21

acebutolol and Death, Sudden, Cardiac

acebutolol has been researched along with Death, Sudden, Cardiac in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Death, Sudden, Cardiac: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Steriotis, AK1
Nava, A1
Rampazzo, A1
Basso, C1
Thiene, G1
Daliento, L1
Folino, AF1
Rigato, I1
Mazzotti, E1
Beffagna, G1
Carturan, E1
Corrado, D1
Bauce, B1

Other Studies

1 other study available for acebutolol and Death, Sudden, Cardiac

ArticleYear
Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations.
    The American journal of cardiology, 2012, Apr-01, Volume: 109, Issue:7

    Topics: Acebutolol; Adolescent; Adult; Anti-Arrhythmia Agents; Cohort Studies; Death, Sudden, Cardiac; Echoc

2012